Investigational Drug Services University of Kansas Hospital — Kansas City, Kansas

Investigational Drug Services University of Kansas Hospital is a clinical research site located in Kansas City, Kansas, United States 66103.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Drug Services University of Kansas Hospital has participated in 1 clinical trials.

Therapeutic areas: Systemic Lupus Erythematosus.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Drug Services University of Kansas Hospital?

Investigational Drug Services University of Kansas Hospital has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Drug Services University of Kansas Hospital conducted?

Investigational Drug Services University of Kansas Hospital has 1 clinical trials on record. Their work covers Systemic Lupus Erythematosus.

Is Investigational Drug Services University of Kansas Hospital accredited by Crixeo Health?

Investigational Drug Services University of Kansas Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Drug Services University of Kansas Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.